Akari Therapeutics Announces Further Clinical Trial Progress Using Nomacopan to Treat COVID-19 Pneumonia

NEXT STORY
Dental Implants Market to Exhibit 5.1% CAGR and Reach USD 5725 Million by 2026; Straumann to Dominate with its Diverse Product Portfolio, says Fortune Business Insights
PREV STORY
Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MannKind Corporation Reports 2017 Second Quarter Financial Results

VALENCIA, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today reported ...

author_avatar
NASDAQ Market News

125,000 Orion Corporation A shares converted into B shares

ORION CORPORATION      STOCK EXCHANGE RELEASE 12 APRIL 2016 at 9.00 a.m. EEST               125,000 ...

author_avatar
NASDAQ Market News

Affimed to Speak at Symposium on Emerging Approaches in Cancer Immunotherapy

HEIDELBERG, Germany, Feb. 22, 2016 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq:AFMD), a clinical stage ...

author_avatar
NASDAQ Market News